Sickle Cell Disease Trial, Recruiting NCT06385886 Sponsor: RTI International Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT06385886
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older.
  • You must have a confirmed diagnosis of Sickle Cell Disease (SCD).
  • You must not have seen a Sickle Cell Disease specialist in more than a year (give or take about 3 months).
  • You, or your parent/guardian if applicable, must be able to read and understand English.

Who may not be able to join:

  • You are under 18 years of age.
  • You are unable to give your own consent to participate and do not have a caregiver who can consent on your behalf.
  • You have sickle cell trait (rather than Sickle Cell Disease), as shown by a specific blood test called hemoglobin electrophoresis.
  • You have seen a Sickle Cell Disease specialist within the last year (give or take about 3 months).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julie Kanter, MD, University of Alabama, Birmingham (UAB)

Phone: 770-407-4908

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
RTI International
Registry
ClinicalTrials.gov
Start date
8 June 2023
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Identification of unaffiliated patients; Affiliation with a Sickle cell disease (SCD)-specific care with SCD specialist

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov